Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Once-daily formulation of paroxetine submitted for FDA review

March 3, 1998

Milestone reached in Corvas/Pfizer NIF collaboration

March 3, 1998

Antioxidant and neuroprotective effects of GSNO confirmed

March 2, 1998

Canadian approval obtained for Mirapex

Feb. 27, 1998

Antimigraine agents with reduced liability for side effects developed at MS&D

Feb. 27, 1998

AIT-082 enters multidose study

Feb. 27, 1998

Rizatriptan approved in The Netherlands

Feb. 27, 1998

First NDA filing for Sonata

Feb. 26, 1998

IL-6 suggested to be an endogenous neuroprotective factor

Feb. 26, 1998

SSRIs appear safe for use during pregnancy

Feb. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...